JOHNSON & JOHNSON (JNJ) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $17.8M. Most recent filing: Sept. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 10, 2026 filed Sept. 8, 2026 | Pinto Daniel E Director | $31,250 | 113 | 0% | No | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 8, 2026 | Woods Eugene A. Director | $37,500 | 136 | 0% | No | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 8, 2026 | HEWSON MARILLYN A Director | $50,000 | 181 | 0% | No | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | Schmid Timothy EVP, WW Chair, MedTech | $4,797,652 | 100,791 | — | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Taubert Jennifer L EVP, WWC. Innovative Medicine | $2,215,350 | 45,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free